Exploring the role of EZH2 modulation in shaping the tumor microenvironment.
作者信息
Fischetti Irene, De Luca Michele, Jachetti Elena
机构信息
Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Integrated Biology of Rare Tumors Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
出版信息
Epigenomics. 2024;16(19-20):1265-1268. doi: 10.1080/17501911.2024.2410693. Epub 2024 Oct 10.
Abstract
摘要
相似文献
1
Exploring the role of EZH2 modulation in shaping the tumor microenvironment.探索EZH2调控在塑造肿瘤微环境中的作用。
Epigenomics. 2024;16(19-20):1265-1268. doi: 10.1080/17501911.2024.2410693. Epub 2024 Oct 10.
2
ARID1A-driven modulation of EZH2 impedes proliferation and enhances senescence in breast cancer cells.ARID1A驱动的EZH2调节可抑制乳腺癌细胞增殖并增强其衰老。
Biochim Biophys Acta Gene Regul Mech. 2025 Jun 19;1868(3):195102. doi: 10.1016/j.bbagrm.2025.195102.
3
The Role of EZH2 in Initiating Epigenetic Regulation of CRSwNP.EZH2在启动慢性鼻-鼻窦炎伴鼻息肉（CRSwNP）表观遗传调控中的作用
J Inflamm Res. 2025 Jul 1;18:8607-8628. doi: 10.2147/JIR.S525688. eCollection 2025.
4
EZH2 regulates tumor-associated macrophages by the KDM6A-mediated inflammatory response in HPV16-positive cervical cancer.EZH2通过KDM6A介导的炎症反应在HPV16阳性宫颈癌中调节肿瘤相关巨噬细胞。
Hum Cell. 2025 Jun 19;38(4):119. doi: 10.1007/s13577-025-01246-3.
5
Fungi and cancer: unveiling the complex role of fungal infections in tumor biology and therapeutic resistance.真菌与癌症：揭示真菌感染在肿瘤生物学和治疗耐药性中的复杂作用
Front Cell Infect Microbiol. 2025 Jun 10;15:1596688. doi: 10.3389/fcimb.2025.1596688. eCollection 2025.
6
The dual functionality of EZH2 in cardiovascular disease: Bridging cancer biology and cardiac pathophysiology through epigenetic regulation, metabolic reprogramming, and novel therapeutic interventions.EZH2在心血管疾病中的双重功能：通过表观遗传调控、代谢重编程和新型治疗干预连接癌症生物学与心脏病理生理学
Curr Probl Cardiol. 2025 Jun 13;50(9):103104. doi: 10.1016/j.cpcardiol.2025.103104.
7
Deciphering the tumor immune microenvironment: single-cell and spatial transcriptomic insights into cervical cancer fibroblasts.解析肿瘤免疫微环境：对宫颈癌成纤维细胞的单细胞和空间转录组学见解
J Exp Clin Cancer Res. 2025 Jul 5;44(1):194. doi: 10.1186/s13046-025-03432-5.
8
Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of ΔNp63α expression and promote breast cancer metastasis independent of HIF1α.缺氧激活的 XBP1s 招募 HDAC2-EZH2 以参与 ΔNp63α 表达的表观遗传抑制，并独立于 HIF1α 促进乳腺癌转移。
Cell Death Differ. 2024 Apr;31(4):447-459. doi: 10.1038/s41418-024-01271-z. Epub 2024 Feb 27.
9
Cancer-Derived Exosomal LINC01615 Induces M2 Polarization of Tumor-Associated Macrophages via RBMX-EZH2 Axis to Promote Colorectal Cancer Progression.癌症来源的外泌体LINC01615通过RBMX-EZH2轴诱导肿瘤相关巨噬细胞的M2极化以促进结直肠癌进展。
Int J Nanomedicine. 2025 Jun 11;20:7343-7358. doi: 10.2147/IJN.S499381. eCollection 2025.
10
Structural characteristics and SARs of EZH2 inhibitors.EZH2抑制剂的结构特征与构效关系
Mol Divers. 2025 Jul 1. doi: 10.1007/s11030-025-11272-w.
引用本文的文献
1
Oncogenic Role of Aberrant EZH2 in Hepatoblastoma.异常EZH2在肝母细胞瘤中的致癌作用。
bioRxiv. 2025 Aug 1:2025.07.30.667506. doi: 10.1101/2025.07.30.667506.
本文引用的文献
1
Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response.针对雄激素受体（AR）和EZH2的联合疗法可抑制去势抵抗性前列腺癌，增强抗肿瘤T细胞反应。
Epigenomics. 2024 Mar 26;16(9):653-70. doi: 10.2217/epi-2023-0374.
2
EZH2-mediated development of therapeutic resistance in cancer.EZH2 介导的癌症治疗抵抗的发生。
Cancer Lett. 2024 Apr 1;586:216706. doi: 10.1016/j.canlet.2024.216706. Epub 2024 Feb 7.
3
Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinic.EZH2 蛋白稳定性的调控：新机制、在肿瘤发生中的作用和走向临床。
EBioMedicine. 2024 Feb;100:104972. doi: 10.1016/j.ebiom.2024.104972. Epub 2024 Jan 19.
4
Regulation of CCL2 by EZH2 affects tumor-associated macrophages polarization and infiltration in breast cancer.EZH2 对 CCL2 的调控影响乳腺癌中肿瘤相关巨噬细胞的极化和浸润。
Cell Death Dis. 2022 Aug 29;13(8):748. doi: 10.1038/s41419-022-05169-x.
5
The Role of Polycomb Proteins in Cell Lineage Commitment and Embryonic Development.多梳蛋白在细胞谱系定向分化和胚胎发育中的作用
Epigenomes. 2022 Aug 12;6(3):23. doi: 10.3390/epigenomes6030023.
6
EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment.EZH2 抑制剂通过调节肿瘤微环境中的巨噬细胞极化抑制结直肠癌。
Front Immunol. 2022 Apr 1;13:857808. doi: 10.3389/fimmu.2022.857808. eCollection 2022.
7
EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy.EZH2，实体瘤微环境和免疫治疗的遗传与表观遗传调控的重要协调因子。
Biochim Biophys Acta Rev Cancer. 2022 Mar;1877(2):188700. doi: 10.1016/j.bbcan.2022.188700. Epub 2022 Feb 22.
8
Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling.miR-144/451a 簇的表观遗传沉默通过旁分泌 HGF/MIF 介导的 TAM 重塑促进 HCC 进展。
Mol Cancer. 2021 Mar 3;20(1):46. doi: 10.1186/s12943-021-01343-5.
9
EZH2: a novel target for cancer treatment.EZH2：癌症治疗的新靶点。
J Hematol Oncol. 2020 Jul 28;13(1):104. doi: 10.1186/s13045-020-00937-8.
10
EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells.EZH2 抑制剂 GSK126 通过驱动髓系来源的抑制细胞产生来抑制抗肿瘤免疫。
Cancer Res. 2019 Apr 15;79(8):2009-2020. doi: 10.1158/0008-5472.CAN-18-2395. Epub 2019 Feb 8.
Zotero 插件